Opendata, web and dolomites

MABIOS SIGNED

The first microalgae platform for the production of anticancer biopharmaceuticals

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MABIOS project word cloud

Explore the words cloud of the MABIOS project. It provides you a very rough idea of what is the project "MABIOS" about.

engineered    urgent    yields    cancer    dutch    pharmaceutical    organisms    living    patient    opportunity    biopharmaceuticals    proof    rate    biorefinery    first    algae    affordable    roadmap    solid    price    molecules    consuming    manufacture    peptides    mabios    line    clear    plan    ingredients    biopharmaceutical    proteins    lines    works    drugs    tumours    platform    frontrunner    patients    world    limited    market    advantages    starting    paclitaxel    yield    agents    companies    de    utilize    oncologic    mission    biorefineries    cell    utilizing    anticancer    difficult    microalgae    sold    investor    requiring    active    cultivation    therapeutic    manufacturing    demand    lower    showcase    small    regulatory    revolutionize    business    scalable    expensive    create    purification    unmet    photosynthetic    obstacles    recombinant    treatment    micro    biomanufacturing    ease    formulate    start    overview    treatments    drastic    enter    time    genetically    meet    risked   

Project "MABIOS" data sheet

The following table provides information about the project.

Coordinator
MICROALGAE WORKS BV 

Organization address
address: BARGELAAN 200
city: LEIDEN
postcode: 2333 CW
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2020-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MICROALGAE WORKS BV NL (LEIDEN) coordinator 50˙000.00

Map

 Project objective

Manufacturing costs remain one of the major obstacles to providing effective treatment of cancer patients. Anticancer agents are often complex biopharmaceuticals that are expensive to manufacture, requiring use of living cell lines with difficult-to-control production processes, limited yields and time-consuming purification steps. There is an urgent unmet need for an improved manufacturing process of biopharmaceuticals, to meet the high demand and lower the price of oncologic treatments. We will revolutionize the way biopharmaceuticals are produced by developing a microalgae based biorefinery platform. These biorefineries will utilize genetically engineered microalgae to efficiently produce pharmaceutical agents. Microalgae are photosynthetic micro-organisms that have unique advantages as biopharmaceutical production systems, including high growth rate, ease of cultivation and low growth costs, enabling cost effective and scalable yield of active ingredients. These will be recombinant proteins, small molecules or therapeutic peptides, starting with Paclitaxel as showcase, one of the world’s best sold anticancer drugs used as the first line treatment of a several solid tumours. Our platform has the potential to become the new manufacturing method of choice for production of highly needed biopharmaceuticals. Microalgae Works is an ambitious Dutch start-up with the mission to make anticancer treatment affordable for every patient through a drastic reduction of manufacturing costs. We are supported by leading companies in the field of biomanufacturing. The MABIOS project will (1) create a clear overview of the market opportunity for micro-algae based production of paclitaxel, (2) develop a de-risked plan for the technical development of our platform, (3) evaluate the necessary regulatory roadmap to enter the market, and (4) formulate an investor-proof business plan. We aim to become the frontrunner in biopharmaceutical production utilizing microalgae.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MABIOS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MABIOS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

IMPACT (2019)

Improving DNA Analysis for Correct Healthcare

Read More  

EVERCAM (2020)

Intelligent Vision System for Improved Communication and Higher Productivity in Construction

Read More  

MIGRATECH 4.0 (2019)

The revolution in micro-granulation technology for eco-friendly, production efficient, superior ceramic tiles

Read More